These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 33542929)

  • 1. Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients.
    Jiang N; Li Z; Yang B; Jin M; Sun Y; He Y; Liu Y; Wang Y; Si D; Ma P; Zhang J; Liu T; Yu Q
    Biomed Res Int; 2021; 2021():9101082. PubMed ID: 33542929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Immune Responses of 137 Deceased Patients With COVID-19: A Retrospective Study.
    Cui N; Yan R; Qin C; Zhao J
    Front Cell Infect Microbiol; 2020; 10():595333. PubMed ID: 33365277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
    Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
    Front Immunol; 2021; 12():581469. PubMed ID: 33664741
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19.
    Hasichaolu ; Zhang X; Li X; Li X; Li D
    Biomed Res Int; 2020; 2020():7570981. PubMed ID: 33274223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death.
    Belaid B; Lamara Mahammad L; Mihi B; Rahali SY; Djidjeli A; Larab Z; Berkani L; Berkane I; Sayah W; Merah F; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Ayoub S; Hamidi RM; Derrar F; Gharnaout M; Allam I; Djidjik R
    J Leukoc Biol; 2022 Jan; 111(1):269-281. PubMed ID: 33527487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.
    Han M; Ma K; Wang X; Yan W; Wang H; You J; Wang Q; Chen H; Guo W; Chen T; Ning Q; Luo X
    Front Endocrinol (Lausanne); 2021; 12():596518. PubMed ID: 33776910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes.
    Zeng X; Jiang X; Yang L; Pan Y; Li Y
    J Immunol Res; 2021; 2021():8669098. PubMed ID: 34712741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
    Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
    J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
    J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
    Ni M; Tian FB; Xiang DD; Yu B
    J Med Virol; 2020 Nov; 92(11):2600-2606. PubMed ID: 32470153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.
    Luo Y; Mao L; Yuan X; Xue Y; Lin Q; Tang G; Song H; Wang F; Sun Z
    J Clin Immunol; 2020 Oct; 40(7):960-969. PubMed ID: 32661797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.
    Liu J; Li S; Liu J; Liang B; Wang X; Wang H; Li W; Tong Q; Yi J; Zhao L; Xiong L; Guo C; Tian J; Luo J; Yao J; Pang R; Shen H; Peng C; Liu T; Zhang Q; Wu J; Xu L; Lu S; Wang B; Weng Z; Han C; Zhu H; Zhou R; Zhou H; Chen X; Ye P; Zhu B; Wang L; Zhou W; He S; He Y; Jie S; Wei P; Zhang J; Lu Y; Wang W; Zhang L; Li L; Zhou F; Wang J; Dittmer U; Lu M; Hu Y; Yang D; Zheng X
    EBioMedicine; 2020 May; 55():102763. PubMed ID: 32361250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Exhaustion Levels of NK and CD8
    Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
    Front Immunol; 2020; 11():580237. PubMed ID: 33154753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients With COVID-19 Pneumonia: A Retrospective Case-Control Study.
    Gan J; Li J; Li S; Yang C
    Front Public Health; 2020; 8():299. PubMed ID: 32626680
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte may be a reference index of the outcome of cancer patients with COVID-19.
    Zhang W; Gao Y; Hu G; Chu Q; Yuan X
    Aging (Albany NY); 2021 Mar; 13(6):7733-7744. PubMed ID: 33735106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.
    Qin C; Zhou L; Hu Z; Zhang S; Yang S; Tao Y; Xie C; Ma K; Shang K; Wang W; Tian DS
    Clin Infect Dis; 2020 Jul; 71(15):762-768. PubMed ID: 32161940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.
    Zhang P; Du W; Yang T; Zhao L; Xiong R; Li Y; Geng Y; Lu W; Zhou J
    Int J Immunopathol Pharmacol; 2021; 35():20587384211048567. PubMed ID: 34619994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.